ProPhase Labs Inc (PRPH) - Cumulative Company Assets

This daily price chart shows that the market value of ProPhase Labs, Inc. (PRPH) is 0.00. The business relies on a combination of diagnostic centers and pharmaceutical distribution, which hinders competitor expansion amid strict FDA oversight. Operational efficiency is driven by a streamlined biomaterial transportation system that maintains strict temperature controls. ProPhase Labs, Inc. (PRPH) is currently transforming its core business by acquiring AI services in the field of genomics.

Total assets reflect the aggregate value of the company's resources, calculated reverse-engineered via return on assets (ROA) to verify data quality and protect investor capital. The trend in total assets visualizes the current structural reorganization of ProPhase Labs, Inc. (PRPH), allowing for an assessment of how the decline in COVID-testing revenues and the transition toward genomic developments are impacting the issuer's material base.